Listen to the Latest ‘KFF Health News Minute’
kffhealthnews - The "KFF Health News Minute" brings original health care and health policy reporting from our newsroom to the airwaves each week.
AI Summary: A phase 2 study investigated FGFR inhibition with rogaratinib in succinate dehydrogenase–deficient gastrointestinal stromal tumors. Results reported tumor control in this rare molecular subset, offering a targeted therapeutic approach where options are sparse and validating FGFR as a biologic vulnerability in SDH‑deficient GIST.
Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61
Related Stories
Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128
CRISPR CD33‑deleted allogeneic transplant shows early AML promise / 15 days
Single‑cycle pembrolizumab yields striking responses in dMMR colon cancer / 20 days
Teclistamab outperforms standard regimens in earlier-line relapsed myeloma / 44 hrs
Common asthma drug may overcome immunotherapy resistance in cancers / 11 days
Retifanlimab plus chemotherapy extends survival in advanced squamous anal cancer / 13 days
MYC overactivity enables DNA repair and chemotherapy resistance in tumours / 13 days
Zoldonrasib shows durable responses in KRAS G12D lung cancer / 5 wks
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Long COVID, Clinical Trials, Health IT, Neuroscience and look for the RSS link.
StackHealth Time Machine